Machine Learning

A new AI-driven trading platform promises higher returns, but it enters a landscape grappling with technological risks and regulatory scrutiny.

A new prop trading firm launches with an innovative model and a veteran leader. But Brian Ferdinand's recent personal bankruptcy adds a layer of risk.

The addition of Google and NVIDIA to Si2's OpenAccess board signals a major industry shift toward collaborative, open standards for semiconductor innovation.

Kourtney Kardashian Barker's wellness brand Lemme enters performance nutrition with a science-backed creatine gummy, aiming to mainstream the supplement for women.

A massive partnership aims to build gigawatt-scale data centers for OpenAI's 'Stargate' project, merging AI ambition with immense energy demands.

Sangbo Sim, a long-time LG executive, takes the financial helm at ZKW, a strategic move poised to merge premium lighting with LG's smart mobility vision.

Chinese manufacturer Bosuer unveils a diverse lineup of electric dirt bikes at CES, from the beginner-friendly S5 to the high-performance E72.

After a decade of research, a promising drug for Fragile X syndrome enters a key trial, offering hope for the first-ever targeted treatment for the disorder.

Gartner names Informatica a Leader in data governance, highlighting the critical need for trusted data foundations in an era of explosive AI growth.

Beyond a simple time change, Fortrea's upcoming JPM presentation is a critical test for its new CEO and a key moment to define its future in the CRO market.

A novel drug that glues cancer proteins to the cellular trash system has entered human trials, offering new hope for rare diseases like Ewing sarcoma.

Promising Phase 2 data shows a new DNA immunotherapy for advanced melanoma, delivered via a needle-free jet injector, significantly improves patient outcomes.

As Telus offers nearly 700 severance packages, unions warn of declining service quality, while data reveals a company grappling with cost pressures.

A new alliance aims to advance KFRX06, a unique Parkinson's therapy that goes beyond a single target to potentially offer a more comprehensive treatment.

A new $50M venture fund from Penn, BioNTech, and OUP aims to turn the university's breakthrough research into life-saving therapies faster than ever.

Oulin's new AI Smart Sink, unveiled at CES 2026, uses a large language model to identify food, find recipes, and guide you through cooking.

With a new board appointment and $19M in funding, Enhanced Genomics is leveraging its 3D genomics platform to build its own pipeline of precision therapies.

Automated Industrial Robotics Inc. acquires Ireland's KAON Automation, a strategic move to dominate the high-stakes medical and life sciences market.

After resolving manufacturing hurdles, Camurus' self-administered acromegaly treatment Oclaiz is back on track for US approval, promising new hope for patients.

Akari Therapeutics is advancing a new class of cancer drugs. Its unique PH1 payload kills tumors and activates the immune system, setting up a pivotal 2026.